ethanolamine has been researched along with Cardiovascular Stroke in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pre-treatment with ethanolamine decreased infarct size in isolated mouse or rat hearts subjected to I/R but this infarct sparing effect was lost in cardiomyocyte specific STAT-3 deficient mice." | 1.36 | Ethanolamine is a novel STAT-3 dependent cardioprotective agent. ( Hacking, D; Kelly, RF; Lacerda, L; Lamont, KT; Lecour, S; Opie, LH; Somers, S; Thomas, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, RF | 1 |
| Lamont, KT | 1 |
| Somers, S | 1 |
| Hacking, D | 1 |
| Lacerda, L | 1 |
| Thomas, P | 1 |
| Opie, LH | 1 |
| Lecour, S | 1 |
1 other study available for ethanolamine and Cardiovascular Stroke
| Article | Year |
|---|---|
Ethanolamine is a novel STAT-3 dependent cardioprotective agent.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Cardiovascular Agents; Disease Models, Animal; Dos | 2010 |